These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1698116)

  • 1. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
    Lewandrowski KB; Medeiros LJ; Harris NL
    Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival.
    Medeiros LJ; Picker LJ; Horning SJ; Warnke RA
    Cancer; 1988 May; 61(9):1844-51. PubMed ID: 3355978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Leu-8 antigen by B-cell lymphomas.
    Michie SA; Garcia CF; Strickler JG; Dailey MO; Rouse RV; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):486-90. PubMed ID: 3310610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
    Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
    Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Das Gupta A; Shah VI
    Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. My4 antibody staining of non-Hodgkin's lymphomas.
    Medeiros LJ; Herrington RD; Gonzalez CL; Jaffe ES; Cossman J
    Am J Clin Pathol; 1991 Mar; 95(3):363-8. PubMed ID: 1705092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
    Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
    J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage.
    Shin SS; Ben-Ezra J; Burke JS; Sheibani K; Rappaport H
    Am J Clin Pathol; 1993 Jun; 99(6):658-62. PubMed ID: 8322699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
    Wessel H
    Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
    Salter DM; Krajewski AS; Cunningham S
    J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 expression in non-Hodgkin's lymphoma.
    Piris M; Brown DC; Gatter KC; Mason DY
    Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
    Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
    Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.